麻豆传媒

Amyloid not consistently tied to depressive symptoms in people without dementia

Glatiramer acetate gets new boxed warning

News and commentary from the world of neurology and neuroscience

Findings may have implications for understanding other neurodegenerative diseases

25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs

Three drug approvals in a sample of 24 deviated from others

RNAi drug led to modest changes in disability, severity, and quality of life over 5 years

News and commentary from the world of neurology and neuroscience

1 million adults projected to develop dementia each year by 2060

Florey Dementia Index leverages age and test scores

Abrysvo and Arexvy labels will caution about risk of rare neurologic disorder

News and commentary from the world of neurology and neuroscience

Guidance could reduce lead exposure by about 20% to 30%

No additional risk in older adults newly prescribed the drug, comparative analysis shows